Merck (MRK)
MRKPrice: $121.86
Fair Value: 🔒
🔒score
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascul... more
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, ... more
Description
Shares
| Market Cap | $304.38B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Robert Davis |
| IPO Date | 1978-01-13 | CAGR | 0.08% |
| Employees | 73,000 | Website | www.merck.com |
| Div. Yield | 2.43% | Payout Ratio | 0.43% |
| Buy Back Yield | 0.17% | Total Yield | 2.6% |
MRK chart loading...
Fundamentals
Technicals
| Enterprise Value | $240.58B | P/E Ratio | 16.74 |
| Forward P/E | 12.32 | PEG Ratio | -0.86 |
| P/S Ratio | 5.27 | P/B Ratio | 6.54 |
| P/CF Ratio | 19.86 | P/FCF Ratio | 25.95 |
| EPS | $7.28 | EPS Growth 1Y | 58.7% |
| EPS Growth 3Y | 25.96% | EPS Growth 5Y | 67.48% |
| Revenue Growth 1Y | 1.68% | Gross Margin | 0.77% |
| Operating Margin | 0.35% | Profit Margin | 0.3% |
| ROE | 0.39% | ROA | 0.15% |
| ROCE | 0.22% | Current Ratio | 1.66 |
| Quick Ratio | 1.44 | Cash Ratio | 0.63 |
| Debt/Equity | 0.8 | Interest Coverage | 17.59 |
| Altman Z Score | 4.34 | Piotroski Score | 6 |